Clinical trial
Controlled and Prospective Randomised Study to Compare Complete Lymph Node Dissection Versus Watchful Waiting in Patients With Malignant Melanoma With a Tumour Thickness of 1,0mm+ and Evidence of Metastases in the Sentinel Node
NCT02434107 is registered in ClinicalTrials.gov with University Hospital Tuebingen as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Controlled and Prospective Randomised Study to Compare Complete Lymph Node Dissection Versus Watchful Waiting in Patients With Malignant Melanoma With a Tumour Thickness of 1,0mm+ and Evidence of Metastases in the Sentinel Node
- Lead sponsor
- University Hospital Tuebingen
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- December 31, 2005
- Completion date
- December 31, 2017
- Enrollment
- 483 (actual)
- Sites
- 41
Conditions
As the registry lists them; a condition with its own page is linked.